Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 3
2008 6
2009 3
2010 4
2011 10
2012 7
2013 3
2014 2
2015 7
2016 11
2017 10
2018 7
2019 11
2020 3
2021 6
2022 7
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: maruko i. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: maruko i. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Reply.
Hasegawa T, Kawano T, Maruko I, Koizumi H, Iida T. Hasegawa T, et al. Among authors: maruko i. Retina. 2019 Jun;39(6):e23-e24. doi: 10.1097/IAE.0000000000002524. Retina. 2019. PMID: 30933000 No abstract available.
Reply.
Maruko I, Spaide RF, Koizumi H, Sawaguchi S, Izumi T, Hasegawa T, Arakawa H, Iida T. Maruko I, et al. Retina. 2017 Mar;37(3):e32-e33. doi: 10.1097/IAE.0000000000001528. Retina. 2017. PMID: 28221287 No abstract available.
Reply.
Maruko I, Koizumi H, Kogure-Katakura A, Iida T. Maruko I, et al. Retina. 2017 Jun;37(6):e84. doi: 10.1097/IAE.0000000000001676. Retina. 2017. PMID: 28538617 No abstract available.
Reply.
Hasegawa T, Kawano T, Maruko I, Koizumi H, Iida T. Hasegawa T, et al. Among authors: maruko i. Retina. 2019 Jun;39(6):e25. doi: 10.1097/IAE.0000000000002526. Retina. 2019. PMID: 30932999 No abstract available.
Reply.
Koizumi H, Yamamoto A, Maruko I, Okada AA, Iida T, Kano M, Saito M, Sekiryu T, Kawasaki R. Koizumi H, et al. Among authors: maruko i. Am J Ophthalmol. 2016 Aug;168:287-288. doi: 10.1016/j.ajo.2016.05.004. Epub 2016 Jun 2. Am J Ophthalmol. 2016. PMID: 27265886 No abstract available.
Reply.
Okada AA, Yamamoto A, Koizumi H, Kano M, Saito M, Maruko I, Sekiryu T, Iida T. Okada AA, et al. Among authors: maruko i. Ophthalmology. 2016 Feb;123(2):e13-e14. doi: 10.1016/j.ophtha.2015.08.032. Ophthalmology. 2016. PMID: 26802715 No abstract available.
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study.
Inoda S, Takahashi H, Maruyama-Inoue M, Ikeda S, Sekiryu T, Itagaki K, Matsumoto H, Mukai R, Nagai Y, Ohnaka M, Kusuhara S, Miki A, Okada AA, Nakayama M, Nishiguchi KM, Takeuchi J, Mori R, Tanaka K, Honda S, Kohno T, Koizumi H, Miyara Y, Inoue Y, Takana H, Iida T, Maruko I, Hayashi A, Ueda-Consolvo T, Yanagi Y. Inoda S, et al. Among authors: maruko i. Retina. 2024 Apr 1;44(4):714-722. doi: 10.1097/IAE.0000000000004009. Retina. 2024. PMID: 38016089
101 results